Drawing for ZYBORVENT

USPTO serial 78682375

ZYBORVENT

Reviewed by CopyMark Law Group

Reg. 3179946Status 710
Filing date
Status date
Registration date
Dec 5, 2006
Examiner
MICKLEBURGH, LINDA BOHANNON
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ZYBORVENT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Diane K. Fry

Diane K. Fry GlaxoSmithKlineLGTM, C.3157.3DFive Moore DriveResearch Triangle Park, NC 27709

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccinesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 12, 2013C8..CANCELLED SEC. 8 (6-YR)—
May 12, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 19, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 19, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 5, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 19, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 30, 2006NPUBNOTICE OF PUBLICATION—
Jul 24, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 24, 2006ALIEASSIGNED TO LIE—
Mar 31, 2006ALIEASSIGNED TO LIE—
Mar 30, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 10, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 28, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2006GNSLLETTER OF SUSPENSION E-MAILED—
Feb 20, 2006CNSLSUSPENSION LETTER WRITTEN—
Feb 20, 2006DOCKASSIGNED TO EXAMINER—
Aug 6, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance